Benjamin Siddoway

Sanford Burnham Prebys Medical Discovery Institute

Also affiliated with Discovery Institute, Vertex Pharmaceuticals (United States)

NeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Single-Nucleus RNA-seq of Normal-Appearing Brain Regions in Relapsing-Remitting vs. Secondary Progressive Multiple Sclerosis: Implications for the Efficacy of Fingolimod”.

Single-Nucleus RNA-seq of Normal-Appearing Brain Regions in Relapsing-Remitting vs. Secondary Progressive Multiple Sclerosis: Implications for the Efficacy of Fingolimod

Frontiers in Cellular Neuroscience(2022)10.3389/fncel.2022.918041

N/A

0DataRank · unranked

28 citations

Yunjiao Zhu, Deepa Jonnalagadda, William J. Romanow, Carter R. Palmer, Benjamin Siddoway +5 more

Single-nucleus RNA-seq of normal-appearing brain regions in relapsing-remitting vs. secondary progressive multiple sclerosis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.10.475705

N/A

0DataRank · unranked

1 citations

Yunjiao Zhu, Deepa Jonnalagadda, William J. Romanow, Carter R. Palmer, Benjamin Siddoway +5 more